{
    "organizations": [],
    "uuid": "aa92b6197f17182a610df1777f570e2460de25fc",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-rxi-pharmaceuticals-announces-posi/brief-rxi-pharmaceuticals-announces-positive-results-from-phase-2-trial-with-samcyprone-for-treatment-of-common-warts-idUSASC0A2Y2",
    "ord_in_thread": 0,
    "title": "BRIEF-Rxi Pharmaceuticals Announces Positive Results From Phase 2 Trial With Samcyprone For Treatment Of Common Warts",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 18 (Reuters) - Rxi Pharmaceuticals Corp:\n* RXI PHARMACEUTICALS ANNOUNCES POSITIVE RESULTS FROM PHASE 2 TRIAL WITH SAMCYPRONE™ FOR THE TREATMENT OF COMMON WARTS\n* RXI PHARMACEUTICALS ANNOUNCES POSITIVE RESULTS FROM PHASE 2 TRIAL WITH SAMCYPRONE™ FOR THE TREATMENT OF COMMON WARTS\n* RXI PHARMACEUTICALS CORP - STUDY SUCCESSFULLY MEETS ITS PRIMARY EFFECTIVENESS OBJECTIVES AND ITS SECONDARY SAFETY AND TOLERABILITY OBJECTIVES\n* RXI PHARMACEUTICALS CORP - STUDY RESULTS SHOW THAT SAMCYPRONE WAS SAFE AND WELL TOLERATED Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-19T00:02:00.000+03:00",
    "crawled": "2018-05-19T15:29:30.075+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "rxi",
        "pharmaceutical",
        "corp",
        "rxi",
        "pharmaceutical",
        "announces",
        "positive",
        "result",
        "phase",
        "trial",
        "treatment",
        "common",
        "wart",
        "rxi",
        "pharmaceutical",
        "announces",
        "positive",
        "result",
        "phase",
        "trial",
        "treatment",
        "common",
        "wart",
        "rxi",
        "pharmaceutical",
        "corp",
        "study",
        "successfully",
        "meet",
        "primary",
        "effectiveness",
        "objective",
        "secondary",
        "safety",
        "tolerability",
        "objective",
        "rxi",
        "pharmaceutical",
        "corp",
        "study",
        "result",
        "show",
        "samcyprone",
        "safe",
        "well",
        "tolerated",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}